Cargando…
Uncovering the Benefits of the Ketamine–Dexmedetomidine Combination for Procedural Sedation during the Italian COVID-19 Pandemic
This retrospective observational study evaluated the safety and efficacy of the ketamine and dexmedetomidine combination (keta-dex) compared to ketamine or dexmedetomidine alone for sedation of patients with acute respiratory distress due to COVID-19 pneumonia who require non-invasive ventilation. T...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179324/ https://www.ncbi.nlm.nih.gov/pubmed/37176565 http://dx.doi.org/10.3390/jcm12093124 |
_version_ | 1785041070991605760 |
---|---|
author | Riccardi, Alessandro Serra, Sossio De Iaco, Fabio Fabbri, Andrea Shiffer, Dana Voza, Antonio |
author_facet | Riccardi, Alessandro Serra, Sossio De Iaco, Fabio Fabbri, Andrea Shiffer, Dana Voza, Antonio |
author_sort | Riccardi, Alessandro |
collection | PubMed |
description | This retrospective observational study evaluated the safety and efficacy of the ketamine and dexmedetomidine combination (keta-dex) compared to ketamine or dexmedetomidine alone for sedation of patients with acute respiratory distress due to COVID-19 pneumonia who require non-invasive ventilation. The following factors were assessed: tolerance to the ventilation, sedation level on the Richmond Agitation-Sedation Scale (RASS), hemodynamic and saturation profile, adverse effects, and discontinuation or mortality during ventilation. The study included 66 patients who underwent sedation for non-invasive ventilation using keta-dex (KETA-DEX group, n = 22), ketamine (KET group, n = 22), or dexmedetomidine (DEX group, n = 22). The DEX group showed a slower sedation rate and a significant reduction in blood pressure compared to the KETA-DEX group (p < 0.05). An increase in blood pressure was recorded more frequently in the KET group. No reduction in oxygen saturation and no deaths were observed in any of the groups. None of the patients discontinued ventilation due to intolerance. The mean duration of sedation was 28.12 h. No cases of delirium were observed in any of the groups. Overall, keta-dex was associated with faster sedation rates and better hemodynamic profiles compared to dexmedetomidine alone. Keta-dex is effective and safe for sedation of uncooperative patients undergoing non-invasive ventilation. |
format | Online Article Text |
id | pubmed-10179324 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101793242023-05-13 Uncovering the Benefits of the Ketamine–Dexmedetomidine Combination for Procedural Sedation during the Italian COVID-19 Pandemic Riccardi, Alessandro Serra, Sossio De Iaco, Fabio Fabbri, Andrea Shiffer, Dana Voza, Antonio J Clin Med Brief Report This retrospective observational study evaluated the safety and efficacy of the ketamine and dexmedetomidine combination (keta-dex) compared to ketamine or dexmedetomidine alone for sedation of patients with acute respiratory distress due to COVID-19 pneumonia who require non-invasive ventilation. The following factors were assessed: tolerance to the ventilation, sedation level on the Richmond Agitation-Sedation Scale (RASS), hemodynamic and saturation profile, adverse effects, and discontinuation or mortality during ventilation. The study included 66 patients who underwent sedation for non-invasive ventilation using keta-dex (KETA-DEX group, n = 22), ketamine (KET group, n = 22), or dexmedetomidine (DEX group, n = 22). The DEX group showed a slower sedation rate and a significant reduction in blood pressure compared to the KETA-DEX group (p < 0.05). An increase in blood pressure was recorded more frequently in the KET group. No reduction in oxygen saturation and no deaths were observed in any of the groups. None of the patients discontinued ventilation due to intolerance. The mean duration of sedation was 28.12 h. No cases of delirium were observed in any of the groups. Overall, keta-dex was associated with faster sedation rates and better hemodynamic profiles compared to dexmedetomidine alone. Keta-dex is effective and safe for sedation of uncooperative patients undergoing non-invasive ventilation. MDPI 2023-04-25 /pmc/articles/PMC10179324/ /pubmed/37176565 http://dx.doi.org/10.3390/jcm12093124 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Riccardi, Alessandro Serra, Sossio De Iaco, Fabio Fabbri, Andrea Shiffer, Dana Voza, Antonio Uncovering the Benefits of the Ketamine–Dexmedetomidine Combination for Procedural Sedation during the Italian COVID-19 Pandemic |
title | Uncovering the Benefits of the Ketamine–Dexmedetomidine Combination for Procedural Sedation during the Italian COVID-19 Pandemic |
title_full | Uncovering the Benefits of the Ketamine–Dexmedetomidine Combination for Procedural Sedation during the Italian COVID-19 Pandemic |
title_fullStr | Uncovering the Benefits of the Ketamine–Dexmedetomidine Combination for Procedural Sedation during the Italian COVID-19 Pandemic |
title_full_unstemmed | Uncovering the Benefits of the Ketamine–Dexmedetomidine Combination for Procedural Sedation during the Italian COVID-19 Pandemic |
title_short | Uncovering the Benefits of the Ketamine–Dexmedetomidine Combination for Procedural Sedation during the Italian COVID-19 Pandemic |
title_sort | uncovering the benefits of the ketamine–dexmedetomidine combination for procedural sedation during the italian covid-19 pandemic |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179324/ https://www.ncbi.nlm.nih.gov/pubmed/37176565 http://dx.doi.org/10.3390/jcm12093124 |
work_keys_str_mv | AT riccardialessandro uncoveringthebenefitsoftheketaminedexmedetomidinecombinationforproceduralsedationduringtheitaliancovid19pandemic AT serrasossio uncoveringthebenefitsoftheketaminedexmedetomidinecombinationforproceduralsedationduringtheitaliancovid19pandemic AT deiacofabio uncoveringthebenefitsoftheketaminedexmedetomidinecombinationforproceduralsedationduringtheitaliancovid19pandemic AT fabbriandrea uncoveringthebenefitsoftheketaminedexmedetomidinecombinationforproceduralsedationduringtheitaliancovid19pandemic AT shifferdana uncoveringthebenefitsoftheketaminedexmedetomidinecombinationforproceduralsedationduringtheitaliancovid19pandemic AT vozaantonio uncoveringthebenefitsoftheketaminedexmedetomidinecombinationforproceduralsedationduringtheitaliancovid19pandemic |